Condition

Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

3 shown

Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic PatientsNCT07728318 · 2026-08-12

NOT_YET_RECRUITING

Truway Diagnostic Tools in Primary CareNCT07209527 · 2025-10-01

ENROLLING_BY_INVITATION

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858878 · 2025-03-17

ACTIVE_NOT_RECRUITING

Common interventions

Maridebart cafraglutideDRUG1 PlaceboDRUG1 Standard Oral Antidiabetic Drugs (OADs)OTHER1 Standard Oral Hypoglycemic AgentDRUG1 Tirzepatide + Standard Therapy (Intervention Group)OTHER1 Truway Blood Glucose MonitorDEVICE1 Truway Portable Ultrasound DeviceDEVICE1

Leading sponsors

Akhtar Saeed Medical and Dental College1 Amgen1 Truway Health, Inc.1

Trial status mix

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

Phase mix

EARLY_PHASE11

NA1

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.